This site is intended for healthcare professionals only
LoginRegister
Aurobindo Pharma arm API facility gets 3 observations from USFDAAurobindo Pharma arm CuraTeQ Biologics to commercialize proposed biosimilar to Stelara
Solara Active Pharma Sciences Mangalore facility successfully completes USFDA inspectionZydus Lifesciences concludes USFDA inspection at Ahmedabad facility with nil observations
USFDA nod to JnJ Tremfya for Crohns diseaseJ&J Gets CDSCO Panel Nod To Market Teclistamab sterile liquid in Vials
Bausch + Lomb acquires JnJ eye, contact lens drops brand Blink for USD 106.5 millionBausch + Lomb acquires JnJ eye, contact lens drops brand Blink for USD 106.5 million
GST Council likely to exempt IGST on cancer drug Dinutuximab importGST Council likely to exempt IGST on cancer drug Dinutuximab import
USFDA grants traditional approval for Eisai Leqembi for Alzheimers disease treatmentUSFDA grants traditional approval for Eisai Leqembi for Alzheimer's disease treatment
Pfizer discontinues development of danuglipron for chronic weight managementPfizer invests over Rs 206 crore to buy minority stake in Caribou Biosciences
Cipla US unit recalls 6 batches of Albuterol sulfate inhalation aerosol over container defectCipla US unit recalls 6 batches of Albuterol sulfate inhalation aerosol over container defect
HC relief to Zydus Glucon-D, restrains Cipla from using trademarks Gluco-C, Gluco-DHC relief to Zydus Glucon-D, restrains Cipla from using trademarks Gluco-C, Gluco-D
USFDA rejects Amneal Pharma Parkinsons drug over safety concernsUSFDA rejects Amneal Pharma Parkinson's drug over safety concerns
Janssen-Cilag Guselkumab receives UK nod for Crohns disease, ulcerative colitisJanssen reports positive results from phase 2b FRONTIER 1 trial of JNJ-2113 in plaque psoriasis...
Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome CaseModerna announces global regulatory submissions for respiratory syncytial virus vaccine
X